Reply to T.J. Kruser et al

MeSH terms

• Angiogenesis Inhibitors / therapeutic use*
• Antibodies, Monoclonal, Humanized / therapeutic use*
• Antineoplastic Agents, Alkylating / therapeutic use*
• Bevacizumab / therapeutic use*
• Brain Neoplasms / drug therapy*
• Brain Neoplasms / mortality*
• Brain Neoplasms / therapy*
• Chemoradiotherapy*
• Dacarbazine / analogs & derivatives*
• Female
• Glioblastoma / drug therapy*
• Glioblastoma / mortality*
• Glioblastoma / therapy*
• Humans
• Male
• Quality of Life*